Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ostrand-Rosenberg

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Developmental Biology|November 1, 1977
Human teratoma cells share antigens with mouse teratoma cellsS Ostrand-Rosenberg, M Edidin, M A Jewett
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
Tumor cells present MHC class II-restricted nuclear and mitochondrial antigens and are the predominant antigen presenting cells in vivoL Qi, J M Rojas, S Ostrand-Rosenberg
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1993
Beta 2M-/- knockout mice contain low levels of CD8+ cytotoxic T lymphocyte that mediate specific tumor rejectionE Lamousé-Smith, V K Clements, S Ostrand-Rosenberg
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1983
Multiple splenic lymphoid cell subpopulations regulate H-2 antigen expression on teratocarcinoma cells in vivoS Ostrand-Rosenberg, A L Cohn, J W Sandoz
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 4, 1998
Class II-transfected tumor cells directly present endogenous antigen to CD4+ T cells in vitro and are APCs for tumor-encoded antigens in vivoT D Armstrong, V K Clements, S Ostrand-Rosenberg
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
MHC class II-transfected tumor cells directly present antigen to tumor-specific CD4+ T lymphocytesT D Armstrong, V K Clements, S Ostrand-Rosenberg
Cancer Immunology, Immunotherapy : CII|April 29, 1998
Tumor antigen presentation: changing the rulesT D Armstrong, B A Pulaski, S Ostrand-Rosenberg
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinomaS Ostrand-Rosenberg, M J Grusby, V K Clements
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1991
Abrogation of tumorigenicity by MHC class II antigen expression requires the cytoplasmic domain of the class II moleculeS Ostrand-Rosenberg, C A Roby, V K Clements
Tissue Antigens|May 1, 1996
Expression of MHC Class II and B7-1 and B7-2 costimulatory molecules accompanies tumor rejection and reduces the metastatic potential of tumor cellsS Ostrand-Rosenberg, S Baskar, N Patterson, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Developmental Biology|November 1, 1977
Human teratoma cells share antigens with mouse teratoma cellsS Ostrand-Rosenberg, M Edidin, M A Jewett
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
Tumor cells present MHC class II-restricted nuclear and mitochondrial antigens and are the predominant antigen presenting cells in vivoL Qi, J M Rojas, S Ostrand-Rosenberg
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1993
Beta 2M-/- knockout mice contain low levels of CD8+ cytotoxic T lymphocyte that mediate specific tumor rejectionE Lamousé-Smith, V K Clements, S Ostrand-Rosenberg
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1983
Multiple splenic lymphoid cell subpopulations regulate H-2 antigen expression on teratocarcinoma cells in vivoS Ostrand-Rosenberg, A L Cohn, J W Sandoz
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 4, 1998
Class II-transfected tumor cells directly present endogenous antigen to CD4+ T cells in vitro and are APCs for tumor-encoded antigens in vivoT D Armstrong, V K Clements, S Ostrand-Rosenberg
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
MHC class II-transfected tumor cells directly present antigen to tumor-specific CD4+ T lymphocytesT D Armstrong, V K Clements, S Ostrand-Rosenberg
Cancer Immunology, Immunotherapy : CII|April 29, 1998
Tumor antigen presentation: changing the rulesT D Armstrong, B A Pulaski, S Ostrand-Rosenberg
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinomaS Ostrand-Rosenberg, M J Grusby, V K Clements
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1991
Abrogation of tumorigenicity by MHC class II antigen expression requires the cytoplasmic domain of the class II moleculeS Ostrand-Rosenberg, C A Roby, V K Clements
Tissue Antigens|May 1, 1996
Expression of MHC Class II and B7-1 and B7-2 costimulatory molecules accompanies tumor rejection and reduces the metastatic potential of tumor cellsS Ostrand-Rosenberg, S Baskar, N Patterson, et al.
Pageof 6